MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
MOXGEN-457
Moxgen-457 (Co-amoxiclav) is indicated for the short-term treatment of common bacterial infections such as Upper Respiratory Tract Infections, including ENT, Lower Respiratory Tract Infections, Genitourinary Tract Infections, Skin and Soft Tissue Infections, Bone and Joint Infections, and other infections.
Label
Formulation and Dosage
Indication
Distribution
Label
457 mg / 5 mL
Powder for Suspension
ANTIBACTERIAL
Formulation and Dosage
FORMULATION:
Each 5 mL (1 teaspoonful) of the reconstituted suspension contains:
Amoxicillin (as Trihydrate) USP equivalent to Amoxicillin…………400 mg
Clavulanate Potassium USP equivalent to Clavulanic Acid……….57 mg
Excipients………………………………………………………………………………..q.s.
Indication
Co-Amoxiclav should be used with care in patients with evidence of hepatic dysfunction. Co-Amoxiclav syrups contain aspartame and should be used with caution in patients with phenylketonuria. (ANTIBACTERIAL)
Distribution
FDA Registration Number: DRP-5966-11
Manufacturer: Giyaan Pharma Private Limited
Product Categories
Share this Product:
Other Products
Q-CETYL
Acetylcysteine exerts an intensive mucolytic-fluidifying action on the mucous and mucopurulent secretions by depolymerizing the mucoprotein complexes and the nucleic acids which confer viscosity to the vitreous and purulent component of the sputum and other secretions.
Q-MEP
Omeprazole is used to treat excess stomach acid in conditions such as non cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from the group of medicines called proton pump inhibitors.
SALBUGEN PLUS
The combination of salbutamol with guaifenesin is designed to relieve respiratory obstruction and improve pulmonary ventilation. Respiratory disorders where bronchospasm and excessive secretion of tenacious mucus are complicating factors, e.g. bronchial asthma, chronic bronchitis and emphysema.